Results 111 to 120 of about 25,773 (228)
Background/Aims: We aimed to investigate the clinical importance of quantitative levels of serum hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg), and to detect their correlation with hepatitis B virus (HBV) DNA load, alanine ...
Kaan Demirören +2 more
doaj +1 more source
HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene
Chronic HBV infection is a major cause of hepatocellular carcinoma (HCC). The association between hepatitis B “e” antigen (HBeAg) and HCC is well-established by epidemiological studies.
Manish Kandpal +2 more
core +1 more source
Background: Hepatitis B virus (HBV) infection is a serious public health issue that must be addressed. Aim: The goal of this study was to investigate the correlation between serological status for hepatitis Be antigen (HBeAg)/anti-HBe, serum transaminase
Manoj Kumar +6 more
doaj +1 more source
Necroinflammation grade and fibrosis stage in HBeAg-negative patients.
(A) Necroinflammation grade in HBeAg-negative patients. Significant necroinflammation (≥A2) was found 9.1%, 17.8% and 57.6% in PNALT, ALT 1-2×ULN and >2×ULN group, respectively. (B) Fibrosis stage in HBeAg-positive patients. Significant fibrosis (≥F2) was
Zhanhui Wang (160469) +9 more
core +1 more source
Therapy with currently available oral nucleos(t) ide analogs (NA) in patients with chronic hepatitis B (CHB, HBeAg-positive or -negative) should ultimately aim at preventing progression to cirrhosis and hepatocellular carcinoma.
Hadziyannis, S.J., Vassilopoulos, D.
core +1 more source
Substantial progress has been achieved in antiviral therapy for chronic hepatitis B; however, options for women of child-bearing age with HBeAg-positive chronic hepatitis B remain a challenge.
Liu, Shuai-Wei +5 more
core +1 more source
Distribution of different responders in mothers with different HBeAg status.
Abbreviations: HBeAg, hepatitis B e antigen.
Yu Chen (29959) +3 more
core +1 more source
Background and Aim: The management of patients with chronic Hepatitis B Virus (HBV) HBeAg-negative infection in the indeterminate-grey zone (GZ) remains debatable.
Rodanthi Syrigou +4 more
doaj +1 more source
Response rates in HBeAg-positive and -negative patients.
Response rates in HBeAg-positive and -negative patients.
Jee-Fu Huang (292609) +10 more
core +1 more source
Shaohang Cai,* Zhandong Li,* Tao Yu, Muye Xia, Jie Peng Department of Infectious Diseases and Hepatology Unit, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China *These authors contributed equally to this ...
Cai S, Li Z, Xia M, Yu T, Peng J
core

